FDA is investigating death of another baby who allegedly consumed Abbott Formula

Federal authorities investigate death of another child allegedly killed after consuming baby food made by Abbott Laboratories

Food and Drug Administration (FDA) officials said investigations had begun into the circumstances of a baby who died in January.

They said the FDA was notified of the death on June 10.

Abbott launched a recall of its infant formula and closed its Michigan plant in February after reports of serious bacterial infections in four infants.

Two died, and the FDA said it hadn’t been able to conclusively demonstrate whether Abbott’s formula was the reason for the illnesses or deaths. The company has said there is no evidence to link the formula to the illnesses or deaths.

Regardless, the move exacerbated a multi-manufacturer shortage that started with pandemic supply chain issues, and sparked criticism from the Biden administration for being slow to become aware of and respond to the issue.

Ultimately, the president enacted the Defense Production Act, which gives the government more control over industrial production during emergencies, to direct formula ingredient suppliers to prioritize delivery to formula manufacturers.

He also founded Operation Fly Formula, which instructed the Department of Health and Human Services to import forumula from abroad. At least six countries helped deliver supplies.

In a statement, the agency said, “The investigation into this most recent consumer complaint is in the preliminary stages and the agency will provide an update as soon as it learns more.”

It said the agency had previously reported complaints of nine infant deaths.

Only two were associated with the Abbott Nutrition Sturgis plant investigation, and despite extensive research, the evidence does not rule out a definitive link between these infant deaths and the product produced at Abbott Nutrition’s Sturgis plant.

“The FDA is working day and night to ensure that parents and caregivers can easily find safe and nutritious formula products for every child who needs them,” said FDA Commissioner Robert Califf.

β€œI have personally spoken with infant formula manufacturers in recent weeks and they have all significantly increased their production efforts, resulting in more offerings that will be available on store shelves in the future.”

In a statement to The Independent, Abbott said, “The FDA notified Abbott about this matter last week, but limited product and clinical information was provided to evaluate the matter.”

It added: β€œAt this point, there are no conclusions to be drawn and no evidence suggesting a causal relationship between Abbott’s formulas and this reported case. If additional information is available, we will investigate further as part of our complaint handling process.”

Leave a Comment